Kalmar Corporation
3.3.2026 15:00:00 CET | Globenewswire | Press release
Kalmar Corporation - Managers' transactions - Geber-Teir
Kalmar Corporation - Managers' transactions - Geber-Teir
KALMAR CORPORATION, MANAGERS' TRANSACTIONS, AT 4:00 PM (EET)
Kalmar Corporation - Managers' transactions - Geber-Teir ____________________________________________ Person subject to the notification requirement Name: Geber-Teir, Carina Position: Other senior manager Issuer: Kalmar Corporation LEI: 636700Z25ZQXLMZ3CY73 Notification type: INITIAL NOTIFICATION Reference number: 636700Z25ZQXLMZ3CY73_20260303132708_18 ____________________________________________ Transaction date: 2026-03-02 Venue not applicable Instrument type: SHARE ISIN: FI4000571054 Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details (1): Volume: 13637 Unit price: 0.00 EUR Aggregated transactions (1): Volume: 13637 Volume weighted average price: 0.00 EUR
Additional information:
Carina Geber-Teir, SVP, IR, Marketing & Communications, tel. +358 40 502 4697
About Kalmar
Kalmar (Nasdaq Helsinki: KALMAR) is moving goods in critical supply chains around the world, with the vision to be the forerunner in sustainable material handling equipment and services. The company offers a wide range of industry shaping heavy material handling equipment and services to ports and terminals, distribution centres, manufacturing and heavy logistics. Headquartered in Helsinki, Finland, Kalmar operates globally in over 120 countries and employs approximately 5,300 people. In 2025, the company's sales totalled approximately EUR 1.7 billion. www.kalmarglobal.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
SERB Pharmaceuticals23.10.2026 21:01:27 CEST | Press release
SERB Pharmaceuticals Announces Positive Results from the Post-Authorisation Efficacy Study of Idefirix® (imlifidase) Presented at ASN Kidney Week 2026
F. Hoffmann-La Roche Ltd23.10.2026 19:30:00 CEST | Press release
Roche presents interim phase III data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)
TecDo Technology Co., Limited23.10.2026 18:37:22 CEST | Press release
TGC 2026: Tec-Do Launches Navos Pro for Results-Driven AI for Work
CGTN23.10.2026 18:17:10 CEST | Pressemeddelelse
CGTN: Hvad fortæller historien om 'Half a Quilt' (Et halvt vattæppe) os om Kinas nye lange march?
Genmab A/S23.10.2026 17:55:00 CEST | Press release
Genmab Announces Rinatabart Sesutecan (Rina-S®) Demonstrates Statistically Significant Improvement in Progression-Free Survival and Overall Survival in Patients with Platinum-Resistant Ovarian Cancer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom